肥胖症中的骨髓脂肪组织:以前被低估但有前途的治疗点
Hai Long Yu1, Rui Chen2, Suwen Sun2
1Discipline of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Pulau Pinang, Malaysia.
European journal of medical research
|March 3, 2026
概括
骨髓脂肪组织 (BMAT) 在肥胖中起着关键作用. 准BMAT为肥胖和相关代谢障碍提供了有前途的治疗策略.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 肥胖研究的研究.
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 骨髓脂肪组织 (BMAT) 影响代谢和骨健康.
- 肥胖会改变BMAT在骨髓微环境中的作用.
研究的目的:
- 审查将BMAT与肥胖的发展和进展联系在一起的证据.
- 探索BMAT作为肥胖症的治疗点.
主要方法:
- 对当前证据的文献综述.
- 分析BMAT与肥胖之间的机制联系.
主要成果:
- 在肥胖的骨髓中,BMAT充当动态调节剂.
- BMAT 影响系统能量恒温.
结论:
- BMAT是肥胖症的一个被低估的治疗点.
- 未来的研究应该专注于BMAT向策略和临床验证.
更多相关视频
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
3.1K
10:28Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
12.6K
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
368
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
368
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
